» Articles » PMID: 16397406

Presbyopia: the First Stage of Nuclear Cataract?

Overview
Journal Ophthalmic Res
Specialty Ophthalmology
Date 2006 Jan 7
PMID 16397406
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Presbyopia, the inability to accommodate, affects almost everyone at middle age. Recently, it has been shown that there is a massive increase in the stiffness(1) of the lens with age and, since the shape of the lens must change during accommodation, this could provide an explanation for presbyopia. In this review, we propose that presbyopia may be the earliest observable symptom of age-related nuclear (ARN) cataract. ARN cataract is a major cause of world blindness. The genesis of ARN cataract can be traced to the onset of a barrier within the lens at middle age. This barrier restricts the ability of small molecules, such as antioxidants, to penetrate into the centre of the lens leaving the proteins in this region susceptible to oxidation and post-translational modification. Major protein oxidation and colouration are the hallmarks of ARN cataract. We postulate that the onset of the barrier, and the hardening of the nucleus, are intimately linked. Specifically, we propose that progressive age-dependent hardening of the lens nucleus may be responsible for both presbyopia and ARN cataract.

Citing Articles

Influence of lens thickness on the accommodative range in healthy eyes.

Vermeulen L, Koppen C, Van Os L, Pierscionek B, Rozema J J Optom. 2025; 18(1):100528.

PMID: 39778410 PMC: 11760814. DOI: 10.1016/j.optom.2024.100528.


High ambient temperature may induce presbyopia via TRPV1 activation.

Nakazawa Y, Kuno Y, Shimada H, Nagai N, Hiramatsu N, Takeda S Med Mol Morphol. 2024; 57(4):268-276.

PMID: 38980406 DOI: 10.1007/s00795-024-00391-2.


Adaptive Optical Two-Photon Fluorescence Microscopy Probes Cellular Organization of Ocular Lenses In Vivo.

Paidi S, Zhang Q, Yang Y, Xia C, Ji N, Gong X Invest Ophthalmol Vis Sci. 2023; 64(7):20.

PMID: 37306987 PMC: 10266554. DOI: 10.1167/iovs.64.7.20.


Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation.

Doki Y, Nakazawa Y, Morishita N, Endo S, Nagai N, Yamamoto N Mol Med Rep. 2023; 27(5).

PMID: 36999595 PMC: 10086570. DOI: 10.3892/mmr.2023.12990.


New technology using crystalline lens autofluorescence for presbyopia and cataract grading.

Eom Y, Suh Y, Kim S, Lee Y, Jeon H, Lee S Graefes Arch Clin Exp Ophthalmol. 2023; 261(7):1923-1932.

PMID: 36826601 DOI: 10.1007/s00417-023-05999-1.